Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.
作者信息
Raj Anuradha, Gupta Vikas, Krishnamoorthi Sivanantham, Kaur Harmeet, Saini Vaibhav
机构信息
Department of Ophthalmology, All India Institute of Medical Sciences, Bathinda, Punjab, India.
Department of Otorhinolaryngology, All India Institute of Medical Sciences, Bathinda, Punjab, India.
出版信息
Indian J Ophthalmol. 2024 Oct 1;72(10):1519-1523. doi: 10.4103/IJO.IJO_2799_23. Epub 2024 Sep 27.
Abstract
摘要
相似文献
1
Effect of the staging of rhino-orbital-cerebral mucormycosis on its management and clinical outcome.鼻眶脑型毛霉菌病分期对其治疗及临床结局的影响。
Indian J Ophthalmol. 2024 Oct 1;72(10):1519-1523. doi: 10.4103/IJO.IJO_2799_23. Epub 2024 Sep 27.
2
Bilateral Rhino-Orbital-Cerebral Mucormycosis.双侧鼻眶脑毛霉菌病
JAMA Ophthalmol. 2024 Jul 1;142(7):e236486. doi: 10.1001/jamaophthalmol.2023.6486. Epub 2024 Jul 18.
3
Rhino-orbital mucormycosis and aspergillosis: differences in outcome, clinical and imaging characteristics.鼻眶毛霉菌病和曲霉菌病：结局、临床及影像学特征的差异
Eur Arch Otorhinolaryngol. 2010 Jan;267(1):161-2. doi: 10.1007/s00405-009-1136-z. Epub 2009 Nov 5.
4
Orbital exenteration: A dilemma in mucormycosis presented with orbital apex syndrome.眼眶内容剜除术：毛霉病伴眶尖综合征的一个难题。
Am J Rhinol. 2008 Jan-Feb;22(1):98-103. doi: 10.2500/ajr.2008.22.3121.
5
Rhino-orbital-cerebral mucormycosis. A retrospective analysis and treatment option.鼻眶脑毛霉菌病。一项回顾性分析及治疗选择。
Indian J Ophthalmol. 2004 Mar;52(1):82; author reply 82-3.
6
[Rhino-orbito-cerebral mucormycosis].[鼻眶脑毛霉菌病]
Tunis Med. 2013 Feb;91(2):164-5.
7
Rhinocerebral mucormycosis with perineural spread.伴有神经周围扩散的鼻脑型毛霉菌病。
Ophthalmic Plast Reconstr Surg. 2007 Jul-Aug;23(4):326-7. doi: 10.1097/IOP.0b013e318070855b.
8
Rhino-orbito-cerebral mucormycosis.鼻眶脑毛霉菌病
Braz J Otorhinolaryngol. 2009 Jul-Aug;75(4):619. doi: 10.1016/s1808-8694(15)30505-x.
9
Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities.不进行眶内容剜除术成功治疗鼻眶毛霉菌病：多种治疗方式的应用
Ophthalmic Plast Reconstr Surg. 2001 Jan;17(1):62-6. doi: 10.1097/00002341-200101000-00012.
10
Liver cirrhosis and rhino-orbital mucormycosis, a possible but rare association: description of a clinical case and literature review.肝硬化和鼻眶脑毛霉菌病，一种可能但罕见的关联：临床病例描述及文献复习。
Braz J Infect Dis. 2009 Aug;13(4):314-6. doi: 10.1590/s1413-86702009000400015.
本文引用的文献
1
Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.高血糖和类固醇的使用增加了 rhino-orbito-cerebral mucormycosis 的风险，与 COVID-19 住院无关：病例对照研究，印度。
PLoS One. 2022 Aug 8;17(8):e0272042. doi: 10.1371/journal.pone.0272042. eCollection 2022.
2
COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients.COVID-19 相关毛霉菌病至急诊科就诊：70 例患者的观察性研究。
QJM. 2021 Nov 5;114(7):464-470. doi: 10.1093/qjmed/hcab190.
3
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病：全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
4
Rise of the phoenix: Mucormycosis in COVID-19 times.凤凰涅槃：新冠时期的毛霉菌病。
Indian J Ophthalmol. 2021 Jun;69(6):1563-1568. doi: 10.4103/ijo.IJO_310_21.
5
Code Mucor: Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19.毛霉代码：2019冠状病毒病背景下鼻眶脑型毛霉病的诊断、分期和管理指南
Indian J Ophthalmol. 2021 Jun;69(6):1361-1365. doi: 10.4103/ijo.IJO_1165_21.
6
Corticosteroids for treating mild COVID-19: opening the floodgates of therapeutic misadventure.用于治疗轻度新冠肺炎的皮质类固醇：打开治疗不当风险的闸门。
QJM. 2021 Nov 5;114(8):541-542. doi: 10.1093/qjmed/hcab138.
7
Mucor in a Viral Land: A Tale of Two Pathogens.霉菌在病毒之地：两种病原体的故事。
Indian J Ophthalmol. 2021 Feb;69(2):244-252. doi: 10.4103/ijo.IJO_3774_20.
8
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.全球毛霉病诊断和管理指南：欧洲医学真菌学会联合会与真菌感染研究组教育和研究联盟合作开展的一项倡议。
Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5.
9
Mucormycosis in Iran: A six-year retrospective experience.伊朗的毛霉病：六年回顾性经验。
J Mycol Med. 2018 Jun;28(2):269-273. doi: 10.1016/j.mycmed.2018.02.014. Epub 2018 Mar 12.
10
Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.糖尿病作为墨西哥毛霉病的主要危险因素：报告病例的流行病学、诊断及转归
Med Mycol. 2018 Jan 1;56(1):29-43. doi: 10.1093/mmy/myx017.
Zotero 插件